PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Internal Medicine Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Pneumologia Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Short Stay Unit, Doctor Peset University Hospital, Valencia, Spain.\', \'Emergency Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Critical Care Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Anaesthesiology and Postsurgical Critical Care Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Preventive Medicine Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Clinical Microbiology Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Radiology Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Occupational Risk Prevention Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Health Information Management Department, Doctor Peset University Hospital, Valencia, Spain.\', \'Chief Executive Officer, Doctor Peset University Hospital, Valencia, Spain.\', \'Medical Director, Doctor Peset University Hospital, Valencia, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ijcp.14479
?:doi
?:hasPublicationType
?:journal
  • International journal of clinical practice
is ?:pmid of
?:pmid
?:pmid
  • 34107137
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.892
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of intermediate to high doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-induced severe systemic inflammation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all